Edward J Tanner
Overview
Explore the profile of Edward J Tanner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
1082
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fox R, Brandon K, Badger T, Gaumond J, Morales A, Ong J, et al.
Transl Behav Med
. 2025 Feb;
15(1).
PMID: 39907220
Background: Sleep disturbance is among the most frequent and distressing symptoms reported by gynecologic cancer survivors. Existing evidence-based behavioral sleep interventions are limited by implementation burden, which can decrease adherence....
2.
Chen C, Malpani A, Waldram M, Romanczyk C, Tanner E, Fader A, et al.
Int Urogynecol J
. 2023 Jul;
34(11):2751-2758.
PMID: 37449987
Introduction And Hypothesis: The objective was to study the effect of immediate pre-operative warm-up using virtual reality simulation on intraoperative robot-assisted laparoscopic hysterectomy (RALH) performance by gynecology trainees (residents and...
3.
Foley O, Vega B, Roque D, Hinchcliff E, Marcus J, Tanner E, et al.
Int J Gynecol Cancer
. 2023 Jul;
33(11):1778-1785.
PMID: 37423639
Objective: Anemia is prevalent in patients with gynecologic cancers and is associated with increased peri-operative morbidity. We aimed to characterize risk factors for pre-operative anemia and describe outcomes among patients...
4.
Chen S, Xie P, Cowan M, Huang H, Cardenas H, Keathley R, et al.
J Clin Invest
. 2022 Jun;
132(14).
PMID: 35671108
BackgroundImmune checkpoint inhibitors (ICIs) have modest activity in ovarian cancer (OC). To augment their activity, we used priming with the hypomethylating agent guadecitabine in a phase II study.MethodsEligible patients had...
5.
Zhang Y, Wang Y, Zhao G, Tanner E, Adli M, Matei D
J Clin Invest
. 2022 Mar;
132(10).
PMID: 35349489
Understanding the regulatory programs enabling cancer stem cells (CSCs) to self-renew and drive tumorigenicity could identify new treatments. Through comparative chromatin-state and gene expression analyses in ovarian CSCs versus non-CSCs,...
6.
Fox R, Gaumond J, Zee P, Kaiser K, Tanner E, Ancoli-Israel S, et al.
Front Neurosci
. 2022 Mar;
16:818718.
PMID: 35310101
Sleep difficulties, particularly symptoms of insomnia and circadian disruption, are among the primary complaints of gynecologic cancer survivors before, during, and after treatment. Moreover, difficulty sleeping has been linked to...
7.
Fischer J, Mejia-Bautista M, Vadasz B, Yin P, Bulun S, Tanner E, et al.
Int J Gynecol Pathol
. 2022 Jan;
41(6):552-565.
PMID: 35093974
Leiomyoma with bizarre nuclei (LM-BN) is a rare variant of leiomyoma with overall benign clinical course. It has histologic features showing focal or diffuse nuclear atypia surrounded by usual type...
8.
Beavis A, Najjar O, Murdock T, Abing A, Fader A, Wethington S, et al.
Int J Gynecol Cancer
. 2021 Oct;
31(11):1410-1415.
PMID: 34610972
Objective: Plasma energy ablation vaporizes tissues similar to carbon dioxide laser ablation, but is not hindered by the unique hazards and regulation of laser technology. We aimed to evaluate the...
9.
Guo X, Tanner E, Pavone M
J Adolesc Young Adult Oncol
. 2021 May;
10(6):654-660.
PMID: 33960835
To determine how young patients with early-stage endometrial cancer are counseled regarding fertility preserving therapy and pregnancy options by gynecologic oncology and reproductive endocrinology and infertility (REI) providers. Anonymous online...
10.
Banet N, Shahi M, Batista D, Yonescu R, Tanner E, Fader A, et al.
Am J Surg Pathol
. 2021 Mar;
45(5):708-715.
PMID: 33739786
Human epidermal growth factor receptor 2 (HER-2) targeted therapy shows promising results in HER-2-positive uterine serous carcinoma (USC). HER-2 scoring criteria for USC and its associated noninvasive lesion, serous endometrial...